BlackRock’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.87B | Buy |
|
|||||
|
2025
Q1 | $5.66B | Buy |
|
|||||
|
2024
Q4 | $6.22B | Buy |
|
|||||
|
2024
Q3 | $8.91B | Buy |
|
|||||
|
2024
Q2 | $8.88B | Sell |
|
|||||
|
2024
Q1 | $8.25B | Sell |
|
|||||
|
2023
Q4 | $7.58B | Sell |
|
|||||
|
2023
Q3 | $7.3B | Sell |
|
|||||
|
2023
Q2 | $6.53B | Sell |
|
|||||
|
2023
Q1 | $7.74B | Buy |
|
|||||
|
2022
Q4 | $6.61B | Sell |
|
|||||
|
2022
Q3 | $6.54B | Sell |
|
|||||
|
2022
Q2 | $5.61B | Sell |
|
|||||
|
2022
Q1 | $6.69B | Sell |
|
|||||
|
2021
Q4 | $6.07B | Buy |
|
|||||
|
2021
Q3 | $5.67B | Buy |
|
|||||
|
2021
Q2 | $5.05B | Sell |
|
|||||
|
2021
Q1 | $4.57B | Sell |
|
|||||
|
2020
Q4 | $4.72B | Sell |
|
|||||
|
2020
Q3 | $5.48B | Buy |
|
|||||
|
2020
Q2 | $6.11B | Buy |
|
|||||
|
2020
Q1 | $3.22B | Buy |
|
|||||
|
2019
Q4 | $2.31B | Sell |
|
|||||
|
2019
Q3 | $1.74B | Buy |
|
|||||
|
2019
Q2 | $1.89B | Buy |
|
|||||
|
2019
Q1 | $2.48B | Buy |
|
|||||
|
2018
Q4 | $2.21B | Buy |
|
|||||
|
2018
Q3 | $2.37B | Sell |
|
|||||
|
2018
Q2 | $2.07B | Sell |
|
|||||
|
2018
Q1 | $2.07B | Sell |
|
|||||
|
2017
Q4 | $2.26B | Sell |
|
|||||
|
2017
Q3 | $2.74B | Sell |
|
|||||
|
2017
Q2 | $3.04B | Buy |
|
|||||
|
2017
Q1 | $2.38B | Buy |
|
|||||
|
2016
Q4 | $65.8M | Sell |
|
|||||
|
2016
Q3 | $82.7M | Buy |
|
|||||
|
2016
Q2 | $65.2M | Buy |
|
|||||
|
2016
Q1 | $53.5M | Sell |
|
|||||
|
2015
Q4 | $107M | Sell |
|
|||||
|
2015
Q3 | $94.8M | Sell |
|
|||||
|
2015
Q2 | $107M | Sell |
|
|||||
|
2015
Q1 | $112M | Sell |
|
|||||
|
2014
Q4 | $103M | Sell |
|
|||||
|
2014
Q3 | $90.6M | Sell |
|
|||||
|
2014
Q2 | $78M | Buy |
|
|||||
|
2014
Q1 | $76.5M | Buy |
|
|||||
|
2013
Q4 | $67.3M | Buy |
|
|||||
|
2013
Q3 | $57.1M | Buy |
|
|||||
|
2013
Q2 | $36.4M | Buy |
|